Status:
UNKNOWN
A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery
Lead Sponsor:
Abington Memorial Hospital
Conditions:
Gynecologic Cancer
Post Operative Pain
Eligibility:
FEMALE
18-99 years
Phase:
PHASE3
Brief Summary
This study evaluates the comparison between liposomal bupivacaine versus bupivacaine HCl in Transversus Abdominis Plane blocks for gynecologic surgery on the length of stay in the hospital, total narc...
Detailed Description
The proposed pilot study is evaluating the use of Exparel ™ in an anesthesia protocol for patients undergoing major lower abdominal gynecologic surgery. Exparel ™ is a formulation of liposomal bupivic...
Eligibility Criteria
Inclusion
- all patients undergoing planned exploratory laparotomy
- TAP blocks placed after the laparotomy incision is closed, but before the patient is awake, and placed under ultrasound guidance with correct identification of the correct abdominal plane.
- Consent for TAP block signed by patients preoperatively by anesthesiology
Exclusion
- All pregnant patients
- All patients under 18 years of age
- minimally invasive surgery such as laparoscopy or robotic assisted laparoscopy
- medical contraindications to use of bupivacaine or liposomal bupivacaine such as severe hepatic and/or renal disease
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03304444
Start Date
August 1 2016
End Date
October 1 2017
Last Update
October 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abington Hospital Jefferson Health
Abington, Pennsylvania, United States, 19001